Skip to main content
SpringerLink
Log in

Acute Demyelinating Emergencies

  • Chapter
  • First Online:
Emergencies in Neurology

  • 603 Accesses

Abstract

Acute demyelinating emergencies usually refer to acute idiopathic inflammatory diseases with white matter involvement of the central nervous system (CNS). Inflammatory demyelinating diseases of the CNS occur worldwide and are the leading cause of non-traumatic neurological disability in young adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siri A, Carra-Dalliere C, Ayrignac X, Pelletier J, Audoin B, Pittion-Vouyovitch S, Debouverie M, Lionnet C, Viala F, Sablot D, Brassat D, Ouallet J-C, Ruet A, Brochet B, Taillandier L, Bauchet L, Derache N, Defer G, Cabre P, de Seze J, Lebrun Frenay C, Cohen M, Labauge P. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. J Neurol. 2015;262(7):1637–45.

    Article  CAS  Google Scholar 

  2. Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15(9):967–81.

    Article  CAS  Google Scholar 

  3. Confavreux C, Vukusic S. The clinical epidemiology of multiple sclerosis. Neuroimaging Clin N Am. 2008;18:589–622.

    Article  Google Scholar 

  4. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008;28:105–20.

    Article  Google Scholar 

  5. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499–505.

    Article  Google Scholar 

  6. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157–74.

    Article  CAS  Google Scholar 

  7. Ouallet J-C, Bodiguel E, Bensa C, Blanc F, Brassat D, Laplaud D, Zephir H, de Seze J, Magy L, Groupe de Re’flexion sur la Scle’rose en Plaques: GRESE. Recommendations for useful serum testing with suspected multiple sclerosis. Rev Neurol (Paris). 2013;169(1):37–46.

    Article  Google Scholar 

  8. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol. 2005;58:840–6.

    Article  Google Scholar 

  9. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.

    Article  Google Scholar 

  10. Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F, MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15(3):292–303.

    Article  Google Scholar 

  11. Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol. 2009;31:439–53.

    Article  CAS  Google Scholar 

  12. Capello E, Mancardi GL. Marburg type and Balò’s concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci. 2004;25(Suppl 4):S361–3.

    Article  Google Scholar 

  13. Weinshenker BG, O’Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878–86.

    Article  CAS  Google Scholar 

  14. Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically-confirmed tumefactive multiple sclerosis. Brain. 2008;131:1759–75.

    Article  CAS  Google Scholar 

  15. De Seze J, Lanctin C, Lebrun C, et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology. 2005;65:1950–3.

    Article  Google Scholar 

  16. De Seze J, Debouverie M, Zephir H, et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007;64:1426–32.

    Article  Google Scholar 

  17. Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol. 2008;28:84–94.

    Article  Google Scholar 

  18. Young NP, Weinshenker BG, Parisi JE, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain. 2010;133:333–48.

    Article  Google Scholar 

  19. Berzero G, Cortese A, Ravaglia S, Marchioni E. Diagnosis and therapy of acute disseminated encephalomyelitis and its variants. Expert Rev Neurother. 2016;16(1):83–101.

    Article  CAS  Google Scholar 

  20. Koelman DLH, Mateen FJ. Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome. J Neurol. 2015;262(9):2013–24.

    Article  CAS  Google Scholar 

  21. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411–28.

    Article  CAS  Google Scholar 

  22. Marchioni E, Ravaglia S, Piccolo G, et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology. 2005;65:1057–65.

    Article  CAS  Google Scholar 

  23. Marchioni E, Ravaglia S, Montomoli C, Tavazzi E, Minoli L, Baldanti F, Furione M, Alfonsi E, Bergamaschi R, Romani A, Piccolo L, Zardini E, Bastianello S, Pichiecchio A, Ferrante P, Delbue S, Franciotta D, Bono G, Ceroni M. Postinfectious neurologic syndromes a prospective cohort study. Neurology. 2013;80(10):882–9.

    Article  Google Scholar 

  24. Llufriu S, Castillo J, Blanco Y, et al. Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months. Neurology. 2009;73:949–53.

    Article  CAS  Google Scholar 

  25. Callen DJ, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009;72:968–73.

    Article  CAS  Google Scholar 

  26. Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ, Dutch Pediatric MS Study Group. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology. 2010;74(18):1412–5.

    Article  CAS  Google Scholar 

  27. Di Pauli F, Höftberger R, Reindl M, Beer R, Rhomberg P, Schanda K, Sato D, Fujihara K, Lassmann H, Schmutzhard E, Berger T. Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflamm. 2015;2(6):e175.

    Article  Google Scholar 

  28. Chabas D, Pelletier D. Sorting through the pediatric MS spectrum with brain MRI. Nat Rev Neurol. 2009;5:186–8.

    Article  Google Scholar 

  29. Peche SS, Alshekhlee A, Kelly J, Lenox J, Mar S. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol. 2013;49(5):329–34.

    Article  Google Scholar 

  30. Krupp LB, Banwell B, Tenembaum S, International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68:S7–S12.

    Article  Google Scholar 

  31. Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E, International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. Sep. 2013;19(10):1261–7.

    Article  Google Scholar 

  32. Pandit L. Transverse myelitis spectrum disorders. Neurol India. 2009;57:126–33.

    Article  Google Scholar 

  33. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–15.

    Article  CAS  Google Scholar 

  34. Popescu BFG, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology. 2015;84(2):148–58.

    Article  CAS  Google Scholar 

  35. Hagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med. 2008;132:1830–4.

    Google Scholar 

  36. Tumani H. Corticosteroids and plasma exchange in multiple sclerosis. J Neurol. 2008;255(Suppl 6):36–42.

    Article  CAS  Google Scholar 

  37. El Alaoui S, Brochet B, Ouallet JC. Modifying therapies used in severe first idiopathic acute inflammatory events within the central nervous system. Neurology. 2009;72(Suppl 3):A36.

    Google Scholar 

  38. McDaneld LM, Fields JD, Bourdette DN, et al. Immunomodulatory therapies in neurologic critical care. Neurocrit Care. 2010;12:132–43.

    Article  Google Scholar 

  39. Sellebjerg F, Barnes D, Filippini G, et al. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol. 2005;12:939–46.

    Article  CAS  Google Scholar 

  40. Multiple Sclerosis Therapy Consensus Group. Escalating immunotherapy of multiple sclerosis. J Neurol. 2004;251:1329–39.

    Article  Google Scholar 

  41. Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58:143–6.

    Article  CAS  Google Scholar 

  42. Rodriguez M, Karnes WE, Bartleson JD, et al. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43:1100–4.

    Article  CAS  Google Scholar 

  43. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology. 1989;39:1143–9.

    Article  CAS  Google Scholar 

  44. Keegan M, König F, McClelland R, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005;366:579–82.

    Article  Google Scholar 

  45. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007;13:128–32.

    Article  CAS  Google Scholar 

  46. Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke K-D, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung H-P, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann J-P, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Bergh FT, Oy U H-v, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Neuromyelitis Optica Study Group. Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses. Ann Neurol. 2016;79(2):206–16.

    Article  CAS  Google Scholar 

  47. Fazekas F, Lublin FD, Li D, et al. Intravenous immunoglobulin in relapsing–remitting multiple sclerosis: a dose-finding trial. Neurology. 2008;71:265–71.

    Article  CAS  Google Scholar 

  48. Roed HG, Langkilde A, Sellebjerg F, et al. A double-blind, randomized trial of IV immuno-globulin treatment in acute optic neuritis. Neurology. 2005;64:804–10.

    Article  CAS  Google Scholar 

  49. O’Connor PW, Goodman A, Willmer-Hulme AJ, et al. Randomized multicenter trial of natalizumab in acute MS relapses. Clinical and MRI effects. Neurology. 2004;62:2038–43.

    Article  Google Scholar 

  50. Craig J, Young CA, Ennis M, et al. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry. 2003;74:1225–30.

    Article  CAS  Google Scholar 

  51. Miller DM, Weinstock-Guttman B, Béthoux F, et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler. 2000;6:267–3.

    Article  CAS  Google Scholar 

  52. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol. 2002;249:100–4.

    Article  CAS  Google Scholar 

  53. Ruprecht K, Klinker E, Dintelmann T, et al. Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology. 2004;63:1081–3.

    Article  CAS  Google Scholar 

  54. Bonnan M, Cabre P. Plasma exchange for severe attacks in the spectrum of central demyelinating disorders. In: Atta-ur-Rahman, editor. Frontiers in clinical drug research: CNS and neurological disorders, Vol. 2, Chapter: 3. Sharjah: Bentham Science; 2013. p. 55–109.

    Google Scholar 

  55. Scott LJ, Figgitt DP. Mitoxantrone: a review of its use in multiple sclerosis. CNS Drugs. 2004;18:379–96.

    Article  CAS  Google Scholar 

  56. De Seze J, Delalande S, Fauchais AL, et al. Myelopathies secondary to Sjögren’s syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids. J Rheumatol. 2006;33:709–11.

    PubMed  Google Scholar 

  57. Neuwelt CM, Lacks S, Kaye BR, et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med. 1995;98:32–41.

    Article  CAS  Google Scholar 

  58. Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, Laneuville P, Lapierre Y, Lee H, Martin L, McDiarmid S, O’Connor P, Ramsay T, Sabloff M, Walker L, Freedman MS. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet. 2016;388(10044):576–85.

    Article  Google Scholar 

  59. Debette S, de Sèze J, Pruvo JP, et al. Long-term outcome of acute and subacute myelopathies. J Neurol. 2009;256:980–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Multiple Sclerosis Center, University of Bordeaux, Hôpital Pellegrin-Tripode, Bordeaux Cedex, France

    Jean-Christophe Ouallet

Authors
  1. Jean-Christophe Ouallet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Christophe Ouallet .

Editor information

Editors and Affiliations

  1. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Mamta Bhushan Singh

  2. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Rohit Bhatia

Rights and permissions

Reprints and permissions

Copyright information

© 2019 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ouallet, JC. (2019). Acute Demyelinating Emergencies. In: Singh, M., Bhatia, R. (eds) Emergencies in Neurology . Springer, Singapore. https://doi.org/10.1007/978-981-13-7381-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7381-7_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7379-4

  • Online ISBN: 978-981-13-7381-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation